Business Description
Korea United Pharm Inc
NAICS : 325412
ISIN : KR7033270000
Share Class Description:
XKRX:033270: Ordinary SharesCompare
Compare
Traded in other countries / regions
033270.Korea IPO Date
1999-11-11Description
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.65 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.37 | |||||
| Interest Coverage | 64.77 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.97 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.3 | |||||
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | 22.4 | |||||
| 3-Year FCF Growth Rate | -8.6 | |||||
| 3-Year Book Growth Rate | 11.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 3.17 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.29 | |||||
| 9-Day RSI | 39.3 | |||||
| 14-Day RSI | 38.43 | |||||
| 6-1 Month Momentum % | -11.92 | |||||
| 12-1 Month Momentum % | -16.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.64 | |||||
| Quick Ratio | 3.27 | |||||
| Cash Ratio | 2.24 | |||||
| Days Inventory | 167.97 | |||||
| Days Sales Outstanding | 56.37 | |||||
| Days Payable | 36.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.23 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 6.3 | |||||
| Forward Dividend Yield % | 2.23 | |||||
| 5-Year Yield-on-Cost % | 2.9 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 6.01 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.94 | |||||
| Operating Margin % | 19.74 | |||||
| Net Margin % | 7.21 | |||||
| FCF Margin % | 2.54 | |||||
| ROE % | 5.36 | |||||
| ROA % | 4.35 | |||||
| ROIC % | 11.84 | |||||
| ROC (Joel Greenblatt) % | 16.16 | |||||
| ROCE % | 8.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.39 | |||||
| Forward PE Ratio | 5.01 | |||||
| PE Ratio without NRI | 9.93 | |||||
| Price-to-Owner-Earnings | 15.6 | |||||
| PEG Ratio | 1.1 | |||||
| PS Ratio | 0.97 | |||||
| PB Ratio | 0.71 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| Price-to-Free-Cash-Flow | 38.25 | |||||
| Price-to-Operating-Cash-Flow | 10.7 | |||||
| EV-to-EBIT | 5.72 | |||||
| EV-to-EBITDA | 4.28 | |||||
| EV-to-Revenue | 0.65 | |||||
| EV-to-FCF | 26.3 | |||||
| Price-to-Projected-FCF | 0.52 | |||||
| Price-to-DCF (Earnings Based) | 0.43 | |||||
| Price-to-DCF (FCF Based) | 1.11 | |||||
| Price-to-Median-PS-Value | 0.57 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.33 | |||||
| Price-to-Graham-Number | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.81 | |||||
| Price-to-Net-Cash | 7.12 | |||||
| Earnings Yield (Greenblatt) % | 17.48 | |||||
| FCF Yield % | 2.63 | |||||
| Forward Rate of Return (Yacktman) % | 15.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korea United Pharm Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 286,519.248 | ||
| EPS (TTM) (â‚©) | 1407 | ||
| Beta | 0.65 | ||
| Volatility % | 22.13 | ||
| 14-Day RSI | 38.43 | ||
| 14-Day ATR (â‚©) | 488.632874 | ||
| 20-Day SMA (â‚©) | 19452.5 | ||
| 12-1 Month Momentum % | -16.14 | ||
| 52-Week Range (â‚©) | 18180 - 28900 | ||
| Shares Outstanding (Mil) | 14.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korea United Pharm Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korea United Pharm Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korea United Pharm Inc Frequently Asked Questions
What is Korea United Pharm Inc(XKRX:033270)'s stock price today?
The current price of XKRX:033270 is â‚©18830.00. The 52 week high of XKRX:033270 is â‚©28900.00 and 52 week low is â‚©18180.00.
When is next earnings date of Korea United Pharm Inc(XKRX:033270)?
The next earnings date of Korea United Pharm Inc(XKRX:033270) is .
Does Korea United Pharm Inc(XKRX:033270) pay dividends? If so, how much?
The Dividend Yield %  of Korea United Pharm Inc(XKRX:033270) is 2.23% (As of Today), Highest Dividend Payout Ratio of Korea United Pharm Inc(XKRX:033270) was 0.22. The lowest was 0.12. And the median was 0.16. The  Forward Dividend Yield % of Korea United Pharm Inc(XKRX:033270) is 2.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers